Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
NCT06233162
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
Febuxostat-Test product
DRUG:
Febuxostat-Reference product
Sponsor
Bio-innova Co., Ltd